Emerging disease information at your fingertips.
Provider
Resources
Providers &
Long Term Care
The resources you need, from treatment guidelines to the newest information on emerging conditions.
Recent Articles
→-
04/24/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized
Requested actions Monovalent Moderna and Pfizer COVID-19 vaccines are no longer authorized for use in the United States. Read below for how to discard and report as waste. Use the new simplified schedule to administer COVID-19 vaccine. People who are 65 years or older or have immune compromise can now get a second bivalent booster … 04/24/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized
-
04/19/23 Health Advisory: Tuberculosis Testing and Treatment for People Newly Arrived from Ukraine
Requested actions Test for tuberculosis (TB) people newly arrived from Ukraine, within 90 days of arriving in the United States. Test result Action Positive IGRA or TST Order chest X-ray. Positive IGRA or TST and normal chest x-ray Offer and encourage latent TB infection (LTBI) treatment. Positive IGRA or TST and abnormal chest x-ray Contact … 04/19/23 Health Advisory: Tuberculosis Testing and Treatment for People Newly Arrived from Ukraine
-
03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis
Requested actions Background Shigellosis is an acute enteric infection. It is an important cause of domestically acquired and travel-associated bacterial diarrhea in the United States. A low infectious dose makes Shigella bacteria easily transmitted from person to person. Consider shigellosis in the differential diagnosis of acute diarrhea, especially in people who: Shigellosis can be a mild, … 03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis